PMC:7205724 / 22937-23259 16 Projects
Annnotations
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T187 | 0-106 | Sentence | denotes | There are ongoing clinical trials for tocilizumab treatment in patients with moderate and severe COVID-19. |
| T188 | 107-322 | Sentence | denotes | Currently, the use of Tocilizumab is recommended for patients with COVID-19 who have warning signs of hyper inflammation, as can be measured by IL6, ferritin, platelet counts, inflammatory markers, and H score [28]. |